tirzepatide loss of exclusivity When will the patents on MOUNJARO expire, and when will generic MOUNJARO be available? Drugs Losing Patent Exclusivity in

"She has lost over 100 pounds and is in the emergency room at least once every two weeks." Barber's weight plummeted to 87 pounds before doctors took her off Ozempic, believing it was the cause of her condition, two years after she starting taking it

One thing to keep in mind: when people first start GLP-1 meds (or any effective weight-loss or diabetes treatment), they might experience temporary vision changes as their body adjusts

If you have been keeping any kind of log during treatment of energy, mood, or how you relate to food day to day continuing that practice through a medication change may give you useful comparison data to bring to your provider

Consider Comorbid Health Conditions Patients with weight-related comorbidities such as type 2 diabetes, sleep apnea, or heart disease may be advised to continue GLP-1 therapy to manage these conditions in conjunction with weight loss